Israel Hodish, MD, PhD is an associate professor at the Division of Metabolism, Endocrinology & Diabetes (MEND), University of Michigan Health System. Dr. Hodish received his bachelor and MD degrees at the Hadassah Medical School at the Hebrew University, Jerusalem, Israel, in 1996. Following residency training in internal medicine, Dr. Hodish completed his PhD degree in 2006 in the field of anti-angiogenic gene therapy at the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Dr. Hodish performed his fellowship training at the Division of Metabolism, Endocrinology and Diabetes, University of Michigan, and joined the faculty in 2007.
Dr. Hodish's area of greatest clinical expertise is in the management of endocrine diseases, particularly adult-onset diabetes.
Dr. Hodish is a co-founder and clinical research lead for Hygieia Inc., located in Livonia, Michigan. The company has created the d-Nav Insulin Management System that utilizes artificial-intelligence and clinical support to facilitate effective and safe insulin therapy in patients with adult-onset diabetes.
